This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kao, A. Articles by Thorarensen, O. Search for Related Content PubMed PubMed Citation Articles by Kao, A. Articles by Thorarensen, O. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACETYLSALICYLIC ACID HEPARIN WARFARIN Medline Plus Health Information Blood Thinners Ulcerative Colitis Social Bookmarking                   What's this?

Anticoagulation Therapy in Cerebral Sinovenous Thrombosis and Ulcerative Colitis in Children

Divisions of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Dennis Dlugos, MD

Divisions of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Jill V. Hunter, MD

EB Singleton Department of Diagnostic Imaging Texas Children's Hospital, Houston, Texas

Petar Mamula, MD

Gastroenterology and Nutrition The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Olafur Thorarensen, MD

Department of Pediatrics Landspitali University Hospital, Iceland

We describe four pediatric patients with ulcerative colitis and cerebral sinovenous thrombosis and review the pediatric and adult literature on the treatment of sinovenous thrombosis. All of our patients had headache as the initial complaint with onset during an ulcerative colitis flare. Evaluation for hypercoagulable states revealed heterozygosity for prothrombin gene mutation and increased homocysteine level in one patient and mild elevation of anticardiolipin antibodies in two patients. Treatment in the acute period included thrombolysis, heparin, and low-molecular-weight heparin. Chronic therapy included warfarin, low-molecular-weight heparin, and aspirin. Peripheral vein thrombosis occurred in two patients while not on antiplatelet or anticoagulation therapy. Neurologic outcome was positive in this series without complications of therapy, suggesting that aggressive therapy should be considered. Although anticoagulation therapy of sinovenous thrombosis is controversial, particularly in the context of intestinal hemorrhage, it can be beneficial given the possibility of an ongoing hypercoagulable state. (J Child Neurol 2002;17:479-482).

Journal of Child Neurology, Vol. 17, No. 7, 479-482 (2002)
DOI: 10.1177/088307380201700702


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. S. Roach, M. R. Golomb, R. Adams, J. Biller, S. Daniels, G. deVeber, D. Ferriero, B. V. Jones, F. J. Kirkham, R. M. Scott, et al. Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young Stroke, September 1, 2008; 39(9): 2644 - 2691. [Abstract] [Full Text] [PDF]

				P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 887S - 968S. [Abstract] [Full Text] [PDF]